4 Things To Know As Feds Ditch 340B ‘Mega Rule’

Emily Jane Cook assessed the impact on the Health Resources and Services Administration of a lawsuit by PhRMA over the Administration’s proposed 340B orphan drug program changes. “In terms of the currently pending litigation, the primary impact will be on the orphan drug provision, but it will guide the manner in which [HRSA] releases program guidance going forward,”Ms. Cook said.